0001306830false12/3100013068302024-05-132024-05-130001306830us-gaap:CommonStockMember2024-05-132024-05-130001306830ce:EURSeniorUnsecuredNotesDue2025Member2024-05-132024-05-130001306830ce:EURSeniorUnsecuredNotesDue2026Member2024-05-132024-05-130001306830ce:EURSeniorUnsecuredNotesDue2027Member2024-05-132024-05-130001306830ce:EURSeniorUnsecuredNotesDue2028Member2024-05-132024-05-130001306830ce:EURSeniorUnsecuredNotesDue2029Member2024-05-132024-05-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2024 (May 13, 2024)
CELANESE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3241098-0420726
   
(State or other jurisdiction
of incorporation)		(Commission File
Number)		(IRS Employer
Identification No.)
222 West Las Colinas Blvd. Suite 900N, Irving, TX 75039
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (972) 443-4000

N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
1.250% Senior Notes due 2025CE /25The New York Stock Exchange
4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐


Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On May 13, 2024, Celanese Corporation (the “Company”) held its 2024 Annual Meeting of Shareholders (the “2024 Annual Meeting”) virtually at www.virtualshareholdermeeting.com/CE2024 and the Company’s shareholders approved an amendment to Article IX of the Company’s Second Amended and Restated Certificate of Incorporation, as amended (the “Restated Certificate”), to add language exculpating certain officers of the Company from certain liabilities and extending to our officers a right to mandatory indemnification. The amendment to the Certificate is more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 21, 2024, in connection with the 2024 Annual Meeting (the “Proxy Statement”). The full text of the amendments to the Certificate is attached as Exhibit 3.1 and is incorporated herein by reference.
The amendment to the Restated Certificate became effective upon the Company’s filing of a Certificate of Amendment to the Restated Certificate with the Secretary of State of the State of Delaware on May 15, 2024.
Item 5.07Submission of Matters to a Vote of Security Holders.
During the 2024 Annual Meeting, the Company’s shareholders were asked to consider and vote upon four proposals: (1) election of ten directors to the Board to serve for a term that expires at the annual meeting of shareholders in 2025 and until their successors are duly elected and qualified or their earlier resignation or retirement; (2) ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for 2024; (3) an advisory vote to approve executive compensation; and (4) approval of the amendment to the Restated Certificate to provide for officer exculpation and indemnification under Delaware law.
As of the 2024 Annual Meeting record date of March 18, 2024, there were 111,563,396 shares of the Company’s Common Stock issued and outstanding and entitled to be voted at the 2024 Annual Meeting, if represented in person or by proxy at the 2024 Annual Meeting. A total of 104,255,925 shares were voted in person or by proxy (93.44% quorum). For each proposal, the shareholder voting results were as follows:
1. Election of Directors. Each of the director nominees was elected to serve for a term which expires at the annual meeting of shareholders in 2025 by the votes set forth in the table below.
NomineeVoted ForVoted AgainstAbstainBroker Non-Votes
Edward G. Galante97,165,0143,363,79752,7603,674,354
Timothy Go100,384,924111,38785,2603,674,354
Kathryn M. Hill98,726,6871,803,67051,2143,674,354
David F. Hoffmeister91,278,1849,241,21062,1773,674,354
Jay V. Ihlenfeld99,111,8471,404,86064,8643,674,354
Deborah J. Kissire92,578,3607,922,64780,5643,674,354
Michael Koening100,143,153354,79583,6233,674,354
Ganesh Moorthy100,286,096209,41686,0593,674,354
Kim K.W. Rucker96,694,8793,831,77354,9193,674,354
Lori J. Ryerkerk97,512,1313,047,74721,6933,674,354
2. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2024 was ratified by the shareholders by the votes set forth in the table below.
Voted ForVoted AgainstAbstain
102,793,7411,424,92737,257
3. Advisory Vote to Approve Executive Compensation. The shareholders approved, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement, by the votes set forth in the table below.
Voted ForVoted AgainstAbstainBroker Non-Votes
99,257,3591,160,371163,8413,674,354
2

4. Approval of Amendment to the Company's Second Amended and Restated Certificate of Incorporation. The Amendment to the Restated Certificate to provide for officer exculpation and indemnification under Delaware law was approved by the shareholders by the votes set forth in the table below.
Voted ForVoted AgainstAbstainBroker Non-Votes
93,298,3237,223,68059,5683,674,354
Item 9.01 Financial Statements and Exhibits
(d) The following exhibits are being furnished herewith:
Exhibit
Number
Description
  
3.1
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document contained in Exhibit 101)
3

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    
 
CELANESE CORPORATION
 
 By:/s/ ASHLEY B. DUFFIE
 Name: Ashley B. Duffie
 Title:Senior Vice President, General Counsel and Corporate Secretary 
 
Date:May 15, 2024
4

STATE OF DELAWARE
CERTIFICATE OF AMENDMENT OF
SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
CELANESE CORPORATION

Celanese Corporation (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

FIRST: The Second Amended and Restated Certificate of Incorporation is hereby amended by deleting Article IX thereof and inserting the following in lieu thereof:

“SECTION 9.1. Limitation of Liability. To the fullest extent permitted by the DGCL as the same exists or may hereafter be amended, a director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except for any liability imposed by law (as in effect from time to time) (i) for any breach of the director's or officer’s duty of loyalty to the Corporation or its stockholders, (ii) for any act or omission not in good faith or which involved intentional misconduct or a knowing violation of law, (iii) of a director under Section 174 of the DGCL, (iv) for any transaction from which the director or officer derived an improper personal benefit or (v) of an officer in any action by or in the right of the Corporation.”

SECTION 9.2 Indemnification of Directors, Officers, Employees or Agents. The Corporation shall, to the fullest extent permitted by the DGCL as the same exists or may hereafter be amended, indemnify its directors and officers where such director or officer is made party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal or administrative, by reason of the fact that the person is or was a director or officer of the Corporation. The Corporation may accord to any current or former director, officer, employee or agent of the Corporation the right to, or regulate the manner of providing to any current or former director, officer, employee or agent of the Corporation, indemnification to the fullest extent permitted by the DGCL.

SECTION 9.3 Adjustments; Amendments. If the DGCL is amended after the date of the filing of this Second Amended and Restated Certificate of Incorporation to authorize corporate action further eliminating or limiting the personal liability of directors or officers or permitting indemnification to a fuller extent, then the liability of a director or officer of the Corporation shall be eliminated or limited, and indemnification shall be extended, in each case to the fullest extent permitted by the DGCL, as so amended from time to time. No repeal or modification of the foregoing provisions of this Article IX by the stockholders shall adversely affect any right or protection of a director of the Corporation existing by virtue of this Article IX at the time of such repeal or modification.”
SECOND : The foregoing amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, said Corporation has caused this certificate to be executed this 13th day of May, 2024.


By:/s/ ASHLEY B. DUFFIE
Name: Ashley B. Duffie
Title:Senior Vice President,General Counsel and Corporate Secretary 

v3.24.1.1.u2
Cover Page
May 13, 2024
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date May 13, 2024
Entity Registrant Name CELANESE CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-32410
Entity Tax Identification Number 98-0420726
Entity Address, Address Line One 222 West Las Colinas Blvd. Suite 900N
Entity Address, City or Town Irving
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75039
City Area Code 972
Local Phone Number 443-4000
Entity Information, Former Legal or Registered Name N/A
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001306830
Amendment Flag false
Current Fiscal Year End Date --12-31
Common Stock, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CE
Security Exchange Name NYSE
1.250% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 1.250% Senior Notes due 2025
Trading Symbol CE /25
Security Exchange Name NYSE
4.777% Senior Notes due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 4.777% Senior Notes due 2026
Trading Symbol CE /26A
Security Exchange Name NYSE
2.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 2.125% Senior Notes due 2027
Trading Symbol CE /27
Security Exchange Name NYSE
0.625% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.625% Senior Notes due 2028
Trading Symbol CE /28
Security Exchange Name NYSE
5.337% Senior Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 5.337% Senior Notes due 2029
Trading Symbol CE /29A
Security Exchange Name NYSE
Celanese (NYSE:CE)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Celanese Charts.
Celanese (NYSE:CE)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Celanese Charts.